The emergence of carbapenem-resistant Klebsiella pneumoniae is considered as a significant global public health challenge, especially in pediatric patients, since the optimal treatment remains undefined. We summarize the therapeutic experience of six cases with carbapenems-resistant Klebsiella pneumoniae infection occurred in pediatric intensive care unit. Related clinical symptoms and examinat...

conclusions the rate of carbapenem resistant a. baumannii isolates were high in this study. since, blaoxa-58-like or mbl genes were not detected, it seems that resistance to carbapenems is related to blaoxa-23-like and blaoxa-24-like. moreover, blaoxa-23-like was the most prevalent oxacillinase (oxa) gene. most of the isolates belonged to one of the four dominant genotypes indicating clonal dis...

Many hospital antimicrobial stewardship programs restrict the availability of selected drugs by requiring prior approval. Carbapenems may be among the restricted drugs, but it is unclear if hospitals that restrict availability actually use fewer carbapenems than hospitals that do not restrict use. Nor is it clear if restriction is related to resistance. We evaluated the relationship between car...

Acinetobacter baumannii is an aerobic non-motile Gram-negative coccobacillus, and it is one of the most important nosocomial pathogens worldwide. The aim of this study was to determine the molecular epidemiology of the outbreak strains. Between March 2011 and March 2014, a total of 205 strains of A. baumannii were isolated from patients at the Nanyang City Center Hospital. The blaOXA-23, blaOXA...

134 P&T® • March 2008 • Vol. 33 No. 3 INTRODUCTION Carbapenems represent a class of beta-lactam antibacterial agents with a broad spectrum of activity against grampositive, gram-negative, and anaerobic bacteria. This class is bactericidal in nature, but it does not cover species of Enterococcus faecium, methicillin-resistant Staphylococcus aureus (MRSA), or Stenotrophomonas maltophilia. Collect...

The carbapenem class of ?-lactams has been optimized against Gram-negative bacteria producing extended-spectrum ?-lactamases by introducing substituents at position C2. Carbapenems are currently investigated for the treatment tuberculosis as these drugs potent covalent inhibitors l,d-transpeptidases involved in mycobacterial cell wall assembly. optimization carbapenems inactivation unusual targ...

BACKGROUND Carbapenems are widely used for the management of bloodstream infections (BSIs) caused by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE). However, the wide use of carbapenems has been associated with carbapenem-resistant Enterobacteriaceae development. METHODS We searched the PubMed and Scopus databases (last search date was on June 1, 2016) looking for studie...